I am once again honored to be chosen as a Los Angeles Top Doctor and recognized by such respected and talented physicians in the community. I plan to continue my dedication to helping others realize the benefits of Ketamine therapy, says Dr. David Mahjoubi of Ketamine Healing Clinic of Los Angeles.
LOS ANGELES (PRWEB)
January 29, 2020
Dr. David Mahjoubi, is a highly trained board-certified Anesthesiologist and owner of Ketamine Healing Clinic of Los Angeles located at 1762 Westwood Boulevard suite 320 in Los Angeles, California 90024. Dr. Mahjoubi is uniquely qualified to administer IV infusion therapy of Ketamine to treat depression symptoms as well as anxiety and chronic pain.
Los Angeles Magazine recently recognized Dr. David Mahjoubi in their coveted “Top Doctor” list for 2020. Dr. Mahjoubi, who also achieved this acknowledgment when the Top Doctor list was first produced three years ago, is listed among a respected group of physicians in the Anesthesiology category. Dr. Mahjoubi was chosen based on the respect earned from his peers and colleagues. The magazine issues a thorough nomination and review process conducted by PRS (Professional Research Services), which involves a peer-to-peer survey and voting from practicing physicians throughout Los Angeles County. Inclusion into Los Angeles’ Magazine’s Top Doctors cannot be purchased, and advertising has no influence on the review process. Dr. Mahjoubi’s valued distinction as a Top Doctor will soon appear in the April 2020 issue of Los Angeles Magazine.
Dr. Mahjoubi is most known for his alternative approach to depression treatment. He is among a very elite group of physicians in the United States to use Ketamine to treat depression as well as chronic pain. As an experienced Anesthesiologist, Dr. Mahjoubi understands Ketamine as a safe anesthetic medication that has been used for over half a century. However, Ketamine’s value in treating major depression symptoms is a breakthrough therapy that is highly sought-after at Dr. Mahjoubi’s Los Angeles clinic. Patients receive a calculated protocol of IV Ketamine infusions and may also choose Dr. Mahjoubi’s exclusive Ketamine intranasal spray for supplementary treatment at home. Patients who are not tolerating anti-depressants or resistant to other forms of depression treatment often make ideal candidates for Ketamine. As a non-opioid and non-addictive therapy, Ketamine has also shown valued efficacy for treating chronic pain and fibromyalgia.
“I am once again honored to be chosen as a Los Angeles Top Doctor and recognized by such respected and talented physicians in the community. I plan to continue my dedication to helping others realize the remarkable benefits of Ketamine therapy,” says Dr. David Mahjoubi of Ketamine Healing Clinic of Los Angeles.
More About Dr. David Mahjoubi of Ketamine Healing Clinic of Los Angeles:
David Mahjoubi, MD is a Diplomate of the American Board of Anesthesiology. He earned his Doctor of Medicine at The Chicago Medical School. Dr. Mahjoubi carries over a decade of experience with intravenous Ketamine, beginning from his residency training at the University of Southern California (USC) + Los Angeles County Medical Center. He is the author of multiple publications in the medical field and holds high honors from his educational years. Following his residency, Dr. Mahjoubi joined the Anesthesia Group at Northridge Hospital Medical Center and became the most active user of IV Ketamine for both conscious sedation and general anesthesia cases. After working at surgical centers throughout Southern California, he quickly noted the beneficial mental health effects of IV Ketamine in many patients post-procedurally. Ketamine Healing Clinic of Los Angeles was thus founded, and now provides a highly effective treatment for patients with treatment-resistant depression and chronic pain.
To learn more about IV or intranasal Ketamine treatment from Dr. David Mahjoubi, please contact the Los Angeles office at (424) 278-4241 or (866) 987-7874. You may also visit their website at http://www.ketaminehealing.com.
Share article on social media or email: